New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 5, 2013
08:09 EDTMDASMedAssets pullback brings attractive entry point, says Lazard Capital
Lazard Capital says the recent pullback in shares of MedAssets provides an attractive entry point as it does not see any change in the company's fundamentals. The firm reiterates a Buy rating on the name with a $22 price target.
News For MDAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 29, 2014
16:23 EDTMDASMedAssets sees FY14 adjusted EPS $1.34-$1.38, consensus $1.35
Sees FY14 revenue $715M-$721M, consensus $703.88M. Prior views were $1.32-$1.40 for EPS and $698M-$710M for revenue.
16:21 EDTMDASMedAssets reports Q3 adjusted EBTIDA $59.5M, up 10.3%
16:20 EDTMDASMedAssets reports Q3 adjusted EPS 34c, consensus 31c
Reports Q3 revenue $175.7M, consensus $172.51M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use